A double-blind, placebo controlled, mult
โ
Philip C. Wood; Professor C. Mark Castleden
๐
Article
๐
1994
๐
John Wiley and Sons
๐
English
โ 527 KB
The present study was designed to determine whether oral tacrine (tetrahydroaminoacridine, THA) improves the symptoms of patients with mild to moderate Alzheimer's disease. The study was a multicentre, randomized doubleblind, placebo controlled, parallel group study with individual determination of